Hillstream Biopharma Inc Inc
Tharimmune Inc. is a clinical-stage biotechnology company based in Chester, NJ, focused on developing a diverse portfolio of therapeutic candidates in immunology, inflammation, and oncology. Its lead clinical asset, TH104, is being advanced for specific indications related to respiratory and nervous system depression in military personnel and responders exposed to high-potency opioids.
In addition to TH104, Tharimmune's expanded pipeline includes treatments for chronic pruritus in primary biliary cholangitis and TH023, a novel approach to autoimmune diseases. The company also leverages its proprietary EpiClick Technology to target unique epitopes against multiple solid tumors through an early-stage multispecific biologic platform.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.